P
PALISADE BIO INC
NASDAQ: PALI (Palisade Bio, Inc.)
Kemas kini terakhir: 11 minit lalu1.13
-0.03 (-2.59%)
| Penutupan Terdahulu | 1.16 |
| Jumlah Dagangan | 2,029,638 |
| Harga / Jualan (P/S) | 396.32 |
| Harga / Buku (P/B) | 1.78 |
| Julat 52 Minggu |
| EPS Cair (TTM) | -6.07 |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 1.09% |
| Nisbah Semasa (MRQ) | 2.84 |
| Aliran Tunai Operasi (OCF TTM) | -11.35 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -7.37 M |
| Pulangan Atas Aset (ROA TTM) | -80.94% |
| Pulangan Atas Ekuiti (ROE TTM) | -170.72% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Biotechnology (US) | Bercampur | Menaik |
| Biotechnology (Global) | Bercampur | Menaik | |
| Stok | Palisade Bio, Inc. | Bercampur | Menurun |
AISkor Stockmoo
| Konsensus Penganalisis | 0.0 |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | 3.0 |
| Purata Bergerak Teknikal | -1.5 |
| Osilator Teknikal | -2.5 |
| Penilaian Relatif | NA |
| Kesihatan Kewangan | 0.0 |
| Persekitaran Makro | -1.3 |
| AI Insight | NA |
| AI Technical | NA |
| Purata | -0.42 |
|
Palisade Bio Inc is a clinical-stage biopharma company focused on identifying and developing therapeutics that protect the integrity of the intestinal barrier. Its portfolio consists of a PALI-2108 for the treatment of IBD, including UC and CD, and is researching PALI-1908. |
|
| Sektor | Healthcare |
| Industri | Biotechnology |
| Gaya Pelaburan | Small Value |
| % Dimiliki oleh Orang Dalam | 0.46% |
| % Dimiliki oleh Institusi | 5.43% |
Pemilikan
| Nama | Tarikh | Syer Dipegang |
|---|---|---|
| Soleus Capital Management, L.P. | 30 Jun 2026 | 13,063,687 |
| Ameriprise Financial Inc | 30 Jun 2026 | 11,081,434 |
| Janus Henderson Group Ltd. | 31 Mar 2026 | 10,689,452 |
| Jupiter Topco Llc | 30 Jun 2026 | 10,689,452 |
| Octagon Capital Advisors Lp | 30 Jun 2026 | 10,276,317 |
| Perceptive Advisors Llc | 30 Jun 2026 | 8,425,065 |
| Ra Capital Management, L.P. | 30 Jun 2026 | 7,124,116 |
| Franklin Templeton Inc | 30 Jun 2026 | 5,785,189 |
| Point72 Asset Management, L.P. | 30 Jun 2026 | 5,253,403 |
| Boxer Capital Management, Llc | 30 Jun 2026 | 4,799,875 |
| Adage Capital Partners Gp, L.L.C. | 30 Jun 2026 | 4,500,000 |
| Eversept Partners, Lp | 30 Jun 2026 | 4,182,785 |
Tiada data dalam julat masa ini.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |